Can scalp chemistry explain stubborn itching without dandruff?

NCT ID NCT07805031

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 04, 2026 · Last updated Sep 04, 2026

Summary

This study examines 132 women with itchy scalps, some with dandruff and some without, to see if the two conditions have different biological signatures. Researchers measure skin oils, moisture loss, and clinical signs like redness and dryness. The goal is to understand what drives pure scalp itching, which may help develop more targeted scalp care.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If the study succeeds, it could point toward better ways to diagnose and treat itchy scalp by revealing its unique biological fingerprints.
What could go wrong
This is an observational study, not a treatment test. It may not capture all causes of itching, and findings may not apply to men or people with other scalp conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

132 people

The number who actually took part.

Started

Apr 2025

Expected to finish

Sep 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Chinese female volunteers aged 18 to 50 residing in Shanghai, China, recruited from the clinical testing center. The study population comprises healthy individuals with normal scalp conditions as well as individuals presenting with scalp pruritus with or without dandruff, stratified into three distinct cohorts based on pruritus VAS scores and adherent dandruff photographic scales (DFS).

Ages

18 to 50 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Female volunteer from 18 to 50 years old, in good general health (physical, mental, and social well-being) according to volunteer self-declaration and investigator's opinion. 2. Female of childbearing potential who is not sexually active, or who is using an effective contraceptive method for at least one month before the beginning of the study and throughout the study. 3. Female of childbearing potential willing to undergo urine pregnancy test. 4. Volunteer has the life habit of washing hair twice to 7 times every week. 5. Volunteer has scalp conditions based on group: a. Group 1 i. Self-declared normal scalp without pruritus, score=0 on pruritus Visual Analog Scale (VAS). ii. Adherent dandruff score ≤0.5 based on Dandruff Photographic Scales (DFS) assessed by dermatologist. b. Group 2 i. Scalp pruritus score ≥4 and ≤8 on pruritus VAS. ii. Adherent dandruff score ≥2 and ≤4 based on DFS assessed by dermatologist. c. Group 3 i. Scalp pruritus score ≥4 and ≤8 on pruritus VAS. ii. Adherent dandruff score ≤0.5 based on DFS assessed by dermatologist. 6. Volunteer with Asian scalp. 7. Volunteer living in Shanghai for at least one year. 8. Volunteer willing and able to fulfil the study requirements and schedule. 9. Volunteer informed about the study objectives and procedures, and able to understand them. 10. Volunteer who has given written informed consent. Exclusion Criteria: 1. Volunteer who is pregnant or lactating or who is planning to become pregnant during the study. 2. Menopausal female (with absence of menstruations for less than one year) or post-menopausal female (with absence of menstruations for more than one year). 3. Volunteer who has hair treatments including hair coloration, bleaching or perm within 3 months before inclusion. 4. Volunteer who has skin cancer, severe autoimmune skin diseases or other moderate or severe skin diseases. 5. Volunteer who has Seborrheic dermatitis, psoriasis, scalp pityriasis, tinea capitis, atopic dermatitis, folliculitis, alopecia or other skin disorders might interfere the assessment on scalp or calves determined by the dermatologist. 6. Volunteer who has diagnosed endocrine disorders (e.g. hypopituitarism, diabetes mellitus, polycystic ovary syndrome), auto-immune medical conditions (e.g. systemic lupus erythematosus (SLE) and Rheumatoid arthritis (RA)), hyper- or hypothyroidism, hypertension or mental illness (e.g. diagnosed depression, schizophrenia, trichotillomania). 7. Volunteer who has active gastrointestinal (GI) bleeding or history of heart or vascular disease. 8. Volunteer who has systemic medication (e.g. steroidal and non-steroidal anti-inflammatory drugs, corticoids, insulin, antihistamines, hormones, antihypertensive, antibiotics such as quinolone, tetracycline, thiazides, fluoroquinolones) within one month before inclusion. 9. Volunteer who has topical treatments of prescription, over-the-counter remedies (e.g. minoxidil, ketoconazole, selenium sulfide lotion) on scalp within 2 months before inclusion. 10. Volunteer who changed her routine shampoo within 2 weeks before inclusion. 11. Volunteer who has conditions considered by the Investigator as sound reasons for disqualification from enrolment into the study, because it might put the individual at significant risk, confound study results or interfere with the individual's participation. 12. Volunteer who declares to be deprived of freedom by administrative or legal decision. 13. Volunteer who cannot be contacted by phone in case of emergency. 14. Volunteer having participated within 30 days before inclusion or currently participating in another clinical study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Dandruff are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Dandruff pityriasis simplex Pruritus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • SGS Standards and Technology Co., Ltd

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.